Vipul Organics (530627)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Profit growth of 27.59% significantly outpacing sales growth of 11.42%, indicating margin expansion or operating leverage
• Piotroski F-Score of 7/9 suggests solid financial fundamentals and good accounting quality
• Specialty chemicals is a niche with potential for customer stickiness, though moat is not proven here
• Double-digit sales growth of 11.42% shows demand traction in the business

Concerns

• Extremely rich valuation: P/E of 68.56 and P/B of 5.02 leave no margin of safety
• PEG of 3.51 implies growth is more than fully priced in, with high risk of de-rating if momentum slips
• Low capital efficiency: ROE of 9.44% and ROCE of 8.64% are unimpressive for such a premium multiple
• Debt/Equity is N/A, so leverage risk cannot be assessed; latest quarter margin is thin at ~4.3% net profit on sales

AI Analysis

This business reminds me that a wonderful business can be a terrible purchase at too high a price. Vipul Organics, a small specialty chemicals player, earns its keep but without the moat-like returns I demand. Book value is ₹36.62, yet the market asks ₹183.80 — over 5 times book — for a company earning just 9.44% on equity. That translates to a paltry earnings yield of roughly 1.5% at a P/E of 68.56. Graham would shake his head. The profit growth of 27.59% is eye-catching, especially against sales growth of 11.42%, suggesting margin expansion. But with a PEG of 3.51, the market has already priced in years of flawless execution. The Piotroski F-Score of 7/9 is a comfort; the company isn't deteriorating financially. Yet I cannot fully assess leverage because debt/equity is not given, and as a value investor I never rely on incomplete information. The latest quarter shows ₹46 Cr in sales and just ₹2 Cr in net profit — a thin 4.3% margin. If the company can scale that margin while keeping growth alive, the premium might someday be justified. But my discipline is to buy with a margin of safety, and at ₹183.80 there is none. A 0.39% dividend yield offers no support. This is an interesting fast grower, but for now it goes on my watchlist, not into my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer